Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: Zeev Hed who wrote (42266)	3/20/2002 2:43:19 PM
From: jjstingray	Respond to of 99280

Zeev, I am going to play devils advocate. Why don't you think this is just a pullback on low volume. This would normally be considered bullish. Is it the low VIX?

To: Zeev Hed who wrote (42266)	3/20/2002 2:44:59 PM
From: wgh613	Read Replies (2) \| Respond to of 99280

BPUR still a Short? 14:41 ET BPUR Biopure Corp announces Hemopure results (13.00 +4.98) Co announces efficacy results for Hemopure from their Phase III clinical trial show an avoidance of red blood cell transfusions in 59.4% of the Hemopure-treated patients at 42 days post surgery, 70.3% at one week post surgery, and 96.3% on the day of surgery.